
Opinion|Videos|August 27, 2026
Where Axatilimab Fits in the Formulary
Zahra Mahmoudjafari, PharmD, BCOP, FHOPA, MBA, discusses how axatilimab fits into formulary placement and treatment sequencing decisions at her institution, including how the multidisciplinary transplant team aligns on when to initiate therapy and whether clinical scenarios exist where the conversation might occur earlier than strictly third-line.
Advertisement
Episodes in this series

Zahra Mahmoudjafari, PharmD,BCOP, FHOPA, MBA, discusses how axatilimab fits into formulary placement and treatment sequencing decisions at her institution, including how the multidisciplinary transplant team aligns on when to initiate therapy and whether clinical scenarios exist where the conversation might occur earlier than strictly third-line.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves First-in-Class Daraxonrasib for Metastatic Pancreatic Cancer
2
FDA Grants Fast Track Designation to CK0803 for Amyotrophic Lateral Sclerosis
3
What Pharmacists Should Know About Novo Nordisk-Eli Lilly GLP-1 Ad Suit
4
Yeast-Based Universal Flu Vaccine Fully Protects Mice Against 3 Influenza Strains
5































































































